DRNA - Dicerna Pharmaceuticals Inc. (DRNA) CEO Doug Fambrough on Q3 2021 Results - Earnings Call Transcript

Dicerna Pharmaceuticals, Inc. (DRNA) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Kristen Sheppard - Senior Vice President of Investor Relations Doug Fambrough - Chief Executive Officer Doug Pagan - Chief Financial Officer Shreeram Aradhye - Chief Medical Officer Conference Call Participants Jonathan Miller - Evercore Mani Foroohar - SVB Leerink Luca Issi - RBC Capital Stephen Willey - Stifel Yigal Nochomovitz - Citigroup Brendan Smith - Cowen Thomas Yip - H. C. Wainwright Madhu Kumar - Goldman Sachs Yuan Zhi - B. Riley Securities Presentation Operator Good morning, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals Third Quarter 2021 Financial Results Conference Call. As a reminder, this conference call is being recorded at the company’s request. I will now turn the call over to your host, Kristen Sheppard, Senior Vice President of Investor Relations at Dicerna. Please go ahead. Kristen Sheppard Thank you,

For further details see:

Dicerna Pharmaceuticals, Inc. (DRNA) CEO Doug Fambrough on Q3 2021 Results - Earnings Call Transcript